Evaluating Telementoring for CHW-centered Diabetes Initiatives

NAActive, not recruitingINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2028

Conditions
Diabetes Mellitus, Type 2
Interventions
OTHER

Intervention

In the proposed study, we will conduct a randomized clinical trial of low-income, adult Latino(a)s with type 2 diabetes randomized at the individual level a telehealth-supported, integrated CHWs, medication-access, diabetes education program) (intervention) versus usual care (UC). Our research team will provide telementoring to local clinic teams (providers and CHWs) to initiate the 12-month the program into their clinics.

Trial Locations (1)

77030

University of Texas Medical Branch, Houston

All Listed Sponsors
collaborator

The University of Texas Health Science Center, Houston

OTHER

collaborator

University of Houston

OTHER

collaborator

Baylor College of Medicine

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

The University of Texas Medical Branch, Galveston

OTHER